What is the list price of TRELEGY?

The list priceList price may also be called the wholesale acquisition cost or WAC. WAC does not include discounts, rebates, and other price adjustments to wholesalers or any other customer. for a 30-day supply of TRELEGY is $545.901, but it's important to keep in mind, the list price is not the price most people usually pay. If you have health insurance, the price you pay – sometimes called your out-of-pocket cost – is set by your prescription drug plan.

To better understand your out-of-pocket cost, contact your insurance provider because they know the details of your plan. For more information, select the option below that best describes your health care coverage.

What can I expect to pay for TRELEGY?

Select the option below that best describes your health care coverage.

If you have prescription drug coverage through work or a private policy, your insurance provider will set a fixed co-pay or co-insurance percentage for you to pay for your prescriptions.

About 81% of TRELEGY prescriptions cost less than $20 per month. The average cost of the remaining prescriptions is $83.72 per month.2

To help ensure the price of your medicine is affordable to you, GSK offers manufacturer coupons for some of its products. For TRELEGY, eligible employer-sponsored or privately insured patients pay no more than $10 a month. To learn more and see if you're eligible, click here.

Medicare prescription drug benefit plans are complex. The cycle of coverage changes throughout the calendar year and you may go through anywhere from 1 to 4 phases of coverageThere are four phases of Medicare Part D coverage: the deductible period, initial coverage period, coverage gap – also called the donut hole, and catastrophic coverage. If you notice a change in the cost of your Medicare Part D-covered drug during the year, you likely entered a different phase of coverage.. Each phase has a different out-of-pocket cost, which means the price you pay for your medicine may change throughout the year.

About 77% of TRELEGY prescriptions cost less than $50 per month. The average cost of the remaining prescriptions is $159.82 per month.2

The amount you pay will depend on your prescription drug benefit plan and what phase of coverage you are in. To better understand your out-of-pocket cost, contact your Medicare Part D Plan Sponsor because they know the details of your plan and what phase of coverage you are in.

If you meet certain income requirements, you may be eligible for Medicaid in addition to Medicare and be automatically enrolled in both programs. This is called being "dual eligible." If you are "dual eligible", your co-pay for prescriptions will be a set low price.

If your income is too high to qualify as dual eligible, you can apply to receive support from the “Extra Help” program, also known as “Low-Income Subsidy.” This program can help you pay a set low co-pay for your prescriptions.

To learn more about these programs, speak with your Medicare Part D Plan Sponsor or visit www.medicare.gov/your-medicare-costs/get-help-paying-costs.

If you don't qualify for additional government assistance, there are still other cost-saving options available. GSK has programs dedicated to making your treatment more affordable. To see if you're eligible for a GSK patient assistance program, click here.

Medicaid is a joint federal and state healthcare coverage program. While federal law requires states to provide coverage for certain groups of people, states may offer additional coverage.

Most Medicaid patients will pay $4 to $9 per month for TRELEGY.3

To learn more about Medicaid in your state and find out if you're eligible, visit https://www.medicaid.gov/medicaid-and-you/index.html

If you do not have prescription drug coverage or if TRELEGY is not covered by your insurance, you will likely pay the list price, plus an additional amount charged by the pharmacy. To better understand your cost, talk to a pharmacist where you purchase your medicine.

If you do not have prescription drug coverage and need help paying, GSK has programs dedicated to making your treatment more affordable. To see if you're eligible for a GSK patient assistance program, click here.

What does list price mean to me?

The list price does not represent the actual price you will pay for a medicine.

The link between list price and what you pay can be confusing. With medicines, a lower list price is no guarantee of a lower out-of-pocket cost. If you have prescription drug coverage, your insurance company is the best resource to understand your out-of-pocket cost. If you do not have prescription drug insurance or if your medicine is not covered by your insurance, talk to a pharmacist where you purchase your medicine to better understand your cost.

Where can I get more information?

  • To learn more about TRELEGY, visit TRELEGY.com.
  • For more accurate information about your out-of-pocket cost, contact your insurance provider as they know the details of your plan.
  • To talk to a GSK representative, call 1-866-398-0020.
    Hours: Monday – Friday, 8:30 am – 5:30 pm ET.

1 Source: GSK Data on File as of April 10, 2019.

2 IQVIA FIA 2.4 data, IQVIA US Market Access Strategy Consulting analysis. Accessed on February 15, 2019. Based on analysis of national pharmacy level data of commercially and Medicare insured patients who filled their prescription at the pharmacy between January 1, 2018 and December 31, 2018. The analysis includes only claims that were paid, or for which price was accepted by patients after using insurance and/or any copay cards, discount cards or other offers, and for which data about the transaction was available. The analysis consisted of fill data for TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol inhalation powder).

3 Centers for Medicare & Medicaid Services (CMS). Medicaid and CHIP Overview for Assisters. Maximum Allowable Copayments Determined by Eligible Population's Household Income. Updated August 2018. https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf Accessed on February 15, 2018.